Literature DB >> 21972054

Is it worth looking? Abdominal imaging after pancreatic cancer resection: a national study.

Elan R Witkowski1, Jillian K Smith, Elizaveta Ragulin-Coyne, Sing-Chau Ng, Shimul A Shah, Jennifer F Tseng.   

Abstract

INTRODUCTION: Abdominal imaging is often performed after pancreatic cancer resection. We attempted to quantify the volume and estimate the cost of complex imaging after pancreatectomy nationwide, and to determine whether their frequent use confers benefit.
METHODS: Patients with pancreatic adenocarcinoma who underwent resection were identified in Surveillance, Epidemiology and End Results-Medicare (1991-2005). Claims for abdominal imaging ≤5 years after resection were analyzed. Patients receiving annual CT scans were identified. Univariate and multivariate analyses were performed. To assess frequency of annual CT scanning in patients with superior survival, the top decile was further analyzed.
RESULTS: Eleven thousand eight hundred fifty studies were performed on 2,217 patients. Ten thousand five hundred forty-two (89%) were CT scans. The median number of scans doubled from three in 1991 to six in 2005 (p < 0.0001). Among patients with sufficient survival to allow for analysis, 51.3% received annual CT scans, while only 32.4% of top-performing patients received annual scans. Univariate analysis of the 10% of patients with superior survival did not reveal any significant benefit associated with annual imaging.
CONCLUSION: Utilization of complex imaging after pancreatic cancer resection has increased substantially among Medicare beneficiaries, driven primarily by an increasing number of CT scans. Our study demonstrated no significant survival benefit among patients who received scans on a routine basis.

Entities:  

Mesh:

Year:  2011        PMID: 21972054     DOI: 10.1007/s11605-011-1699-z

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  13 in total

1.  Estimating health care costs related to cancer treatment from SEER-Medicare data.

Authors:  Martin L Brown; Gerald F Riley; Nicki Schussler; Ruth Etzioni
Journal:  Med Care       Date:  2002-08       Impact factor: 2.983

2.  Redefining mortality after pancreatic cancer resection.

Authors:  James Edward Carroll; Jillian K Smith; Jessica P Simons; Melissa M Murphy; Sing Chau Ng; Shimul A Shah; Zheng Zhou; Jennifer F Tseng
Journal:  J Gastrointest Surg       Date:  2010-09-16       Impact factor: 3.452

3.  Pancreatic cancer in the general population: Improvements in survival over the last decade.

Authors:  Taylor S Riall; William H Nealon; James S Goodwin; Dong Zhang; Yong-Fang Kuo; Courtney M Townsend; Jean L Freeman
Journal:  J Gastrointest Surg       Date:  2006-11       Impact factor: 3.452

4.  Progress for resectable pancreatic [corrected] cancer?: a population-based assessment of US practices.

Authors:  Jessica P Simons; Sing Chau Ng; Theodore P McDade; Zheng Zhou; Craig C Earle; Jennifer F Tseng
Journal:  Cancer       Date:  2010-04-01       Impact factor: 6.860

5.  Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006.

Authors:  Michaela A Dinan; Lesley H Curtis; Bradley G Hammill; Edward F Patz; Amy P Abernethy; Alisa M Shea; Kevin A Schulman
Journal:  JAMA       Date:  2010-04-28       Impact factor: 56.272

6.  National failure to operate on early stage pancreatic cancer.

Authors:  Karl Y Bilimoria; David J Bentrem; Clifford Y Ko; Andrew K Stewart; David P Winchester; Mark S Talamonti
Journal:  Ann Surg       Date:  2007-08       Impact factor: 12.969

7.  National complication rates after pancreatectomy: beyond mere mortality.

Authors:  Jessica P Simons; Shimul A Shah; Sing Chau Ng; Giles F Whalen; Jennifer F Tseng
Journal:  J Gastrointest Surg       Date:  2009-06-09       Impact factor: 3.452

8.  Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?

Authors:  Thomas Schnelldorfer; Adam L Ware; Michael G Sarr; Thomas C Smyrk; Lizhi Zhang; Rui Qin; Rachel E Gullerud; John H Donohue; David M Nagorney; Michael B Farnell
Journal:  Ann Surg       Date:  2008-03       Impact factor: 12.969

9.  Utility of the SEER-Medicare data to identify chemotherapy use.

Authors:  Joan L Warren; Linda C Harlan; Angela Fahey; Beth A Virnig; Jean L Freeman; Carrie N Klabunde; Gregory S Cooper; Kevin B Knopf
Journal:  Med Care       Date:  2002-08       Impact factor: 2.983

10.  Risk adjustment performance of Charlson and Elixhauser comorbidities in ICD-9 and ICD-10 administrative databases.

Authors:  Bing Li; Dewey Evans; Peter Faris; Stafford Dean; Hude Quan
Journal:  BMC Health Serv Res       Date:  2008-01-14       Impact factor: 2.655

View more
  17 in total

Review 1.  Adjuvant treatment for pancreatic ductal carcinoma.

Authors:  T Macarulla; T Fernández; M E Gallardo; O Hernando; A M López; M Hidalgo
Journal:  Clin Transl Oncol       Date:  2017-06-21       Impact factor: 3.405

2.  Trends in imaging after diagnosis of thyroid cancer.

Authors:  Jaime L Wiebel; Mousumi Banerjee; Daniel G Muenz; Francis P Worden; Megan R Haymart
Journal:  Cancer       Date:  2015-01-06       Impact factor: 6.860

3.  Temporal trends in the use of diagnostic imaging for inpatients with pancreatic conditions: How much ionizing radiation are we using?

Authors:  Alexsander K Bressan; Jean-Francois Ouellet; Divine Tanyingoh; Elijah Dixon; Gilaad G Kaplan; Sean C Grondin; Robert P Myers; Rachid Mohamed; Chad G Ball
Journal:  Can J Surg       Date:  2016-06       Impact factor: 2.089

4.  Are We Choosing Surveillance Imaging in Gastric and Pancreatic Cancers Wisely? A Population-Based Study.

Authors:  David L Chan; Matthew Cheung; Craig C Earle; Natalie Coburn; Nicole Mittmann; Farah Rahman; Ning Liu; Simron Singh
Journal:  J Gastrointest Cancer       Date:  2020-03

5.  Post-treatment surveillance of patients with colorectal cancer with surgically treated liver metastases.

Authors:  Omar Hyder; Rebecca M Dodson; Skye C Mayo; Eric B Schneider; Matthew J Weiss; Joseph M Herman; Christopher L Wolfgang; Timothy M Pawlik
Journal:  Surgery       Date:  2013-08       Impact factor: 3.982

6.  A qualitative study of patient and clinician attitudes regarding surveillance after a resection of pancreatic and peri-ampullary cancer.

Authors:  Raymond G Deobald; Eva S W Cheng; Yoo-Joung Ko; Frances C Wright; Paul J Karanicolas
Journal:  HPB (Oxford)       Date:  2014-12-24       Impact factor: 3.647

Review 7.  Intensity of follow-up after pancreatic cancer resection.

Authors:  Jason A Castellanos; Nipun B Merchant
Journal:  Ann Surg Oncol       Date:  2013-10-04       Impact factor: 5.344

8.  Primary Care Versus Oncology-Based Surveillance Following Adjuvant Chemotherapy in Resected Pancreatic Cancer.

Authors:  Haider H Samawi; Yaling Yin; Howard J Lim; Winson Y Cheung
Journal:  J Gastrointest Cancer       Date:  2018-12

9.  Trends and patterns of utilization in post-treatment surveillance imaging among patients treated for hepatocellular carcinoma.

Authors:  Omar Hyder; Rebecca M Dodson; Matthew Weiss; David P Cosgrove; Joseph M Herman; Jean-Francois H Geschwind; Ihab R Kamel; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2013-08-14       Impact factor: 3.452

10.  Impact of surveillance among patients with resected pancreatic cancer following adjuvant chemotherapy.

Authors:  Selina K Wong; Lovedeep Gondara; Daniel J Renouf; Howard J Lim; Jonathan M Loree; Janine M Davies; Sharlene Gill
Journal:  J Gastrointest Oncol       Date:  2021-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.